Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › JP Morgan Healthcare, Day 4: OraSure, Meridian Bioscience, Biocartis, Veracyte

JP Morgan Healthcare, Day 4: OraSure, Meridian Bioscience, Biocartis, Veracyte

Jan 11, 2019
|
Leo O'Connor
|
Monica Heger

SAN FRANCISCO (GenomeWeb) - The 37th annual JP Morgan Healthcare Conference came to a close on Thursday with a few diagnostics companies presenting to attendees who stuck around to the end. Below are brief reports on the presentations and breakout sessions covered by our team at the conference and in our offices in New York.

For all of our previous coverage of the conference, please this page on our website.

OraSure Technologies

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

What's Popular?

In Molecular Diagnostics

  1. Jonathan Rothberg-Led Startup Looks to Bring Disposable POC SARS-CoV-2 Test to Market

    Premium

  2. JP Morgan Healthcare Conference, Day 3: Exact Sciences, Luminex, Danaher, Siemens Healthineers, and More

  3. Report Details COVID-19 Testing Within Federal Government

  4. JP Morgan Healthcare Conference, Day 2: Qiagen, LabCorp, Abbott, and More

  5. At JP Morgan Conference, Quidel CEO Discusses Plan to Enter OTC Infectious Disease Test Market

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.